416 related articles for article (PubMed ID: 24875127)
1. miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2.
Yang M; Shan X; Zhou X; Qiu T; Zhu W; Ding Y; Shu Y; Liu P
Anticancer Agents Med Chem; 2014; 14(6):884-91. PubMed ID: 24875127
[TBL] [Abstract][Full Text] [Related]
2. MiR-503 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R and BCL2.
Wang T; Ge G; Ding Y; Zhou X; Huang Z; Zhu W; Shu Y; Liu P
Chin Med J (Engl); 2014; 127(12):2357-62. PubMed ID: 24931256
[TBL] [Abstract][Full Text] [Related]
3. Involvement of miR-143 in cisplatin resistance of gastric cancer cells via targeting IGF1R and BCL2.
Zhuang M; Shi Q; Zhang X; Ding Y; Shan L; Shan X; Qian J; Zhou X; Huang Z; Zhu W; Ding Y; Cheng W; Liu P; Shu Y
Tumour Biol; 2015 Apr; 36(4):2737-45. PubMed ID: 25492481
[TBL] [Abstract][Full Text] [Related]
4. Celastrol Inhibits the Proliferation and Decreases Drug Resistance of Cisplatin- Resistant Gastric Cancer SGC7901/DDP Cells.
Zhan D; Ni T; Wang H; Lv M; Sunagawa M; Liu Y
Anticancer Agents Med Chem; 2022; 22(2):270-279. PubMed ID: 34053427
[TBL] [Abstract][Full Text] [Related]
5. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.
Xia L; Zhang D; Du R; Pan Y; Zhao L; Sun S; Hong L; Liu J; Fan D
Int J Cancer; 2008 Jul; 123(2):372-379. PubMed ID: 18449891
[TBL] [Abstract][Full Text] [Related]
6. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
Gu Y; Fei Z; Zhu R
Anticancer Drugs; 2020 Apr; 31(4):385-393. PubMed ID: 31913198
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-200c regulates cisplatin resistance by targeting ZEB2 in human gastric cancer cells.
Jiang T; Dong P; Li L; Ma X; Xu P; Zhu H; Wang Y; Yang B; Liu K; Liu J; Xue J; Lv R; Su P; Kong G; Chang Y; Zhao C; Wang L
Oncol Rep; 2017 Jul; 38(1):151-158. PubMed ID: 28534959
[TBL] [Abstract][Full Text] [Related]
8. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines.
Zhu W; Shan X; Wang T; Shu Y; Liu P
Int J Cancer; 2010 Dec; 127(11):2520-9. PubMed ID: 20162574
[TBL] [Abstract][Full Text] [Related]
9. miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1.
Li X; Liang J; Liu YX; Wang Y; Yang XH; Luan BH; Zhang GL; Du J; Wu XH
Pharmazie; 2016 Nov; 71(11):640-643. PubMed ID: 29441968
[TBL] [Abstract][Full Text] [Related]
10. miR‑138‑5p modulates the expression of excision repair cross‑complementing proteins ERCC1 and ERCC4, and regulates the sensitivity of gastric cancer cells to cisplatin.
Ning J; Jiao Y; Xie X; Deng X; Zhang Y; Yang Y; Zhao C; Wang H; Gu K
Oncol Rep; 2019 Feb; 41(2):1131-1139. PubMed ID: 30535472
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-206 facilitates gastric cancer cell apoptosis and suppresses cisplatin resistance by targeting MAPK2 signaling pathway.
Chen Z; Gao YJ; Hou RZ; Ding DY; Song DF; Wang DY; Feng Y
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):171-180. PubMed ID: 30657558
[TBL] [Abstract][Full Text] [Related]
12. Let-7b attenuates cisplatin resistance and tumor growth in gastric cancer by targeting AURKB.
Han X; Zhang JJ; Han ZQ; Zhang HB; Wang ZA
Cancer Gene Ther; 2018 Dec; 25(11-12):300-308. PubMed ID: 30237418
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG6 knockdown inhibits cisplatin resistance and progression of gastric cancer through miR-1297/BCL-2 axis.
Mei J; Liu G; Li R; Xiao P; Yang D; Bai H; Hao Y
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34821362
[TBL] [Abstract][Full Text] [Related]
14. miR-449a Regulates proliferation and chemosensitivity to cisplatin by targeting cyclin D1 and BCL2 in SGC7901 cells.
Hu J; Fang Y; Cao Y; Qin R; Chen Q
Dig Dis Sci; 2014 Feb; 59(2):336-45. PubMed ID: 24248414
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of microRNA-34a enhances the DDP sensitivity of gastric cancer cells by modulating proliferation and apoptosis via targeting MET.
Zhang Z; Kong Y; Yang W; Ma F; Zhang Y; Ji S; Ma EM; Liu H; Chen Y; Hua Y
Oncol Rep; 2016 Oct; 36(4):2391-7. PubMed ID: 27513895
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
Cheng C; Qin Y; Zhi Q; Wang J; Qin C
Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of miRNA-200c on chemotherapy-resistance and cell proliferation of gastric cancer SGC7901/DDP cells.
Chen Y; Zuo J; Liu Y; Gao H; Liu W
Chin J Cancer; 2010 Dec; 29(12):1006-11. PubMed ID: 21114921
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of CASC2 contributes to cisplatin resistance in gastric cancer by sponging miR-19a.
Li Y; Lv S; Ning H; Li K; Zhou X; Xv H; Wen H
Biomed Pharmacother; 2018 Dec; 108():1775-1782. PubMed ID: 30372881
[TBL] [Abstract][Full Text] [Related]
19. miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2.
Zhu W; Zhu D; Lu S; Wang T; Wang J; Jiang B; Shu Y; Liu P
Med Oncol; 2012 Mar; 29(1):384-91. PubMed ID: 21258880
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-101 induces apoptosis in cisplatin-resistant gastric cancer cells by targeting VEGF-C.
Li G; Yang F; Gu S; Li Z; Xue M
Mol Med Rep; 2016 Jan; 13(1):572-8. PubMed ID: 26573417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
